Rivista di formazione e aggiornamento professionale del pediatra e del medico di base, fondata nel 1982. In collaborazione con l'Associazione Culturale Pediatri.
Login Abbonamenti Pubblicazioni Carrello Registrazione Perché registrarsi? Contatti

Problemi speciali

Ipopituitarismo congenito

Congenital hypopituitarism

Patrizia Matarazzo1, Marialia Repici1, Aldo Ravaglia2

1Endocrinologia Pediatrica, Ospedale Infantile Regina Margherita, Città della Salute e della Scienza, Torino
2Pediatra ASL TO 4

Settembre 2015 - pagg. 452 -457

Abstract
A lot of genes govern pituitary gland development, differentiation and function. Mutations in those genes, as well as toxic or infective intrauterine noxae, could derange pituitary gland development, differentiation and function. More precocious is the damage or more extended the genetic mutation, more severe will be the anatomical defect of hypothalamo- pituitary axis and consequently clinical and hormonal picture of congenital hypopituitarism. Hormonal deficiencies can be present at diagnosis in more severe disease or can develop later in life. For this reason, follow up is mandatory in children affected by congenital hypopituitarism. Frequently, congenital hypopituitarism is associated with some disabilities (severe obesity, neuromotor impairment, visual damage, all of them due to midline malformations) that could worse the clinical outcome. Precocious detection and substitutive treatment of hormonal deficiencies, multidisciplinary care, patient/ family education, especially in particular moments of life, as at the transition from paediatric to adulthood structures, are necessary to improve quality of life in children affected by congenital hypopituitarism.
Contenuto riservato

Per leggere l'articolo completo è necessario effettuare il login.

Non sei ancora registrato? Registrati

Bibliografia
1. Bancalari RE, Gregory LC, McCabe MJ, Dattani MT. Pituitary gland development: an update. In: Mullis P-E (Ed). Developmental biology of GH secretion, growth and treatment. Endocr Dev. Basel: Karger, 2012;23:1- 15. 2. Romero CJ, Pine-Twaddel E, Radovick S. Novel mutations associated with combined pituitary hormone deficiency. J Mol Endocrinol 2011;46:R93-R102. 3. Takagi M, Ishii T, Inokuchi M, et al. Gradual loss of ACTH due to a novel mutation in LHX4: comprehensive mutation screening in japanese patients with congenital hypopituitarism. PLoS ONE 2012;7(9):e46008. 4. Webb EA, Dattani MT. Septo-optic dysplasia. Eur J Hum Genet 2010;18:393-7. 5. Lifshitz F. Pediatric endocrinology, fifth Ed. Vol. 2. Growth, adrenal, sexual, thyroid, calcium, and fluid balance disorders (HBK), 2006. 6. Tsai SL, Laffan E, Lawrence S. A retrospective review of pituitary MRI findings in children on growth hormone therapy. Pediatr Radiol 2012;42:799-804. 7. Di Iorgi N, Maghnie M. Pituitary gland imaging and outcome. Endocr Dev 2012;23:16-29. 8. Stanhope R. Transition from paediatric to adult endocrinology: hypopituitarism. Growth Horm IGF Res 2004;14:S85-8.

Corrispondenza: pmatarazzo@cittadellasalute.to.it